Express Licenses: The following Monoclonal Antibodies are currently available for Express Licensing through the Fred Hutchinson Cancer Research Center (FHCRC). These agreements have standard terms and conditions that allow for immediate licensing by companies or individuals who wish to pay license fees using a check.
The conditions and financial terms of Express Licenses apply only to those who complete the Express License process online using this website. If the Express License for a specific technology does not meet your needs, other arrangements can be discussed. Should a modification, addition or amendment be discussed, a fee equal to the Signing Fee shall due to FHCRC with such request.
The FHCRC may have other Monoclonal Antibodies available through standard licensing. Please contact slundgre@fhcrc.org to inquire about antibodies not available through Express Licensing or check the following link www.fhcrc.org/science/tech_trans for “Available Technologies” online.
The antibody list is available here online. If you would like to license any of these antibodies, please complete the FHCRC Express License Agreement below.
Send completed License with License Fee (check made payable to Fred Hutchinson Cancer Research Center) to:
Fred Hutchinson Cancer Research Center
Industry Relations & Technology Transfer
Attention: Express Licensing
P.O. Box 19024, J5-110Seattle, WA 98109-1024
Any modifications to the License terms are subject to the current Agreement Modification Fee of the FHCRC.
Licenses without payment included will be returned to the proposed licensee.
If your company requires a purchase order or other means of payment,
please e-mail slundgre@fhcrc.org.